L. Schmid

In vivo modulation of benzodiazepine receptor function after inhibition of endogenous gamma-aminobutyyric acid synthesis.

E. Brouillet, C. Fuseau, M. Bottlaender, 1997, European journal of pharmacology.

Zolpidem Displays Heterogeneity in Its Binding to the Nonhuman Primate Benzodiazepine Receptor In Vivo

E. Brouillet, C. Fuseau, M. Bottlaender, 1995, Journal of neurochemistry.

Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.

E. Brouillet, C. Fuseau, M. Bottlaender, 1996, The Journal of pharmacology and experimental therapeutics.

In Vivo High Intrinsic Efficacy of Triazolam: A Positron Emission Tomography Study in Nonhuman Primates

C. Crouzel, E. Brouillet, C. Fuseau, 1994, Journal of neurochemistry.

Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors.

M. Kassiou, A. Katsifis, B. Maziére, 1996, Nuclear medicine and biology.

Synthesis and in vivo studies of a specific monoamine oxidase B inhibitor: 5-[4-(benzyloxy)phenyl]-3-(2-cyanoethyl)-1,3,4-oxadiazol-[11C]-2(3H)-one

C. Crouzel, C. Fuseau, L. Schmid, 1996, European Journal of Nuclear Medicine.